Clonazepam acetylation in fast and slow acetylators.

Article Details

Citation

Copy to clipboard

Miller ME, Garland WA, Min BH, Ludwick BT, Ballard RH, Levy RH

Clonazepam acetylation in fast and slow acetylators.

Clin Pharmacol Ther. 1981 Sep;30(3):343-7.

PubMed ID

7273597 [ View in PubMed

]

Abstract

Six slow acetylators (SAs) and six rapid acetylators (RAs), as determined by sulfamethazine (SMZ) phenotyping, were each given a 2-mg oral dose of clonazepam. Ninety-six-hour urine collections from these subjects were analyzed for clonazepam, 7-amino clonazepam (7-AM, clonazepam nitroreduced metabolite), and 7-acetamido clonazepam (7-ACT, N-acetylated 7-AM). The SA group excreted more 7-AM and less 7-ACT than the RA group; mean (+/- Sd) recovered as 7-AM was 22.7 +/- 5.0% for the SA group and 13.6 +/- 4.1% for the RA group and mean (+/- SD) recovered as 7-ACT was 1.5 +/- 0.4% for the SA group and 3.9 +/- 1.8% for the RA group. Both differences were substantial (p less than 0.02 by unpaired t test) and indicate that the rate of acetylation of 7-AM to 7-ACT in the biotransformation of clonazepam is determined by the acetylator phenotype.

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Clonazepam	Arylamine N-acetyltransferase 2	Protein	Humans	Unknown	Substrate	Details